Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

October 17, 2021

Ru(II)/amino acid complexes inhibit the progression of breast cancer cells through multiple mechanism-induced apoptosis.

Journal of Inorganic Biochemistry
Francyelli Mello-AndradeElisângela Silveira-Lacerda
October 17, 2021

AGT serves as a potential biomarker and drives tumor progression in colorectal carcinoma.

International Immunopharmacology
Wei ChenJing Lu
October 17, 2021
Review

CRISPR/Cas9 in cancer therapy: A review with a special focus on tumor angiogenesis.

International Journal of Biological Macromolecules
Krishnasamy Naidu Gopal HariprabuSelvaraj Vimalraj
October 16, 2021
Review

Impact of anesthetics on oncogenic signaling network: a review on propofol and isoflurane.

Fundamental & Clinical Pharmacology
Priyanka SahaDona Sinha
October 16, 2021

Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity.

Matrix Biology : Journal of the International Society for Matrix Biology
Denise PinessiGiulia Taraboletti
October 16, 2021
Review

High-density lipoproteins: A promising tool against cancer.

Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
Alice OssoliMonica Gomaraschi
October 16, 2021

Development of Improved Synthetic Routes to Pixatimod (PG545), a Sulfated Oligosaccharide-Steroid Conjugate.

Bioconjugate Chemistry
Mohit ChhabraVito Ferro
October 15, 2021
Review

Critical appraisal of epigenetic regulation of galectins in cancer.

International Journal of Clinical Oncology
Ashita GadwalPurvi Purohit
October 15, 2021

Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.

Cancer Immunology, Immunotherapy : CII
Kui CaoJinhong Zhu
October 15, 2021

rhFGF20 promotes angiogenesis and vascular repair following traumatic brain injury by regulating Wnt/β-catenin pathway.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Ruili GuoLi Lin
October 14, 2021
Preprint
Open Access

Structure-based Design of CDC42 Effector Interaction Inhibitors For the Treatment of Cancer

BioRxiv : the Preprint Server for Biology
S. JahidAnand K. Ganesan
October 15, 2021
Review
Open Access

Roles of Non-coding RNAs and Angiogenesis in Glioblastoma.

Frontiers in Cell and Developmental Biology
Ebrahim BalandehHamed Mirzaei
October 14, 2021
Review

Pharmacological basis and new insights of deguelin concerning its anticancer effects.

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Zhu Yue LinTang Ze Yao
October 13, 2021

Lenvatinib plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.

Thyroid : Official Journal of the American Thyroid Association
Bruna C BertolJena French

Sign up to follow this feed and discover related papers.

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2021 Meta ULC. All rights reserved
/feed-previews/angiogenesis-inhibitors-to-treat/91da804f-fb64-43c0-b5d5-7a6ecb289e43